Scandinavian Study Group. Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Lancet1984; 1: 868–71.
2.
LivingstoneWKElliottAMCobbsCG. In vitro activity of N-formimidoyl thienamycin against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens and Enterococcus species. Antimicrob Agents Chemother1981; 19: 114–6.
3.
NeuHCLabthavikulP.Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob Agents Chemother1982; 21: 180–7.